Clinical Research Directory
Browse clinical research sites, groups, and studies.
Active Surveillance for Low Risk Prostate Cancer
Sponsor: I.M. Sechenov First Moscow State Medical University
Summary
An active surveillance protocol for patients diagnosed low-risk prostate cancer will be held. We plan to use PSA (prostate-specific antigen) testing, DRE (digital rectal examination), TRUS (transrectal ultrasound), MRI (magnetic resonance imaging) and follow-up biopsies to monitor patients and detect cancer progression in time.
Official title: Active Surveillance Methodology for Low Risk Prostate Cancer
Key Details
Gender
MALE
Age Range
50 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2019-10-01
Completion Date
2026-10
Last Updated
2021-07-22
Healthy Volunteers
No
Conditions
Locations (1)
Institute for Urology and Reproductive Health, Sechenov University.
Moscow, Russia